The Washington Post reported the FDA “is proposing to allow pharmaceutical companies to contradict official safety warnings in sales presentations to customers.” The proposal, supported by manufacturers, would “allow drugmakers to present customers with information that undermines official warnings as long as it comes from a peer-reviewed journal article.” The Post says the proposal has led to criticism from public-health advocates that it could “possibly endanger patients” and drug companies could “easily mislead customers” by presenting “only a selection of new research.”
From the news release of the American Association for Justice.


